Blood thinners and gastrointestinal endoscopy.

Area of Science:

• Gastroenterology
• Cardiology
• Internal Medicine

Background:

• Increasing numbers of diagnostic and therapeutic gastrointestinal endoscopies are being performed.
• A growing patient population requires anticoagulant or antiplatelet therapy (blood thinners).
• Managing patients on blood thinners undergoing endoscopic procedures presents unique challenges.

Purpose of the Study:

• To provide endoscopists with a clear understanding of various blood thinners.
• To outline the assessment of periendoscopic risks for patients on anticoagulation.
• To guide safe management strategies for patients on blood thinners undergoing gastrointestinal endoscopy.

Main Methods:

• Review of current literature on anticoagulants and antiplatelet agents.
• Analysis of bleeding risks associated with gastrointestinal endoscopic procedures.
• Evaluation of thromboembolic risks in patients temporarily discontinuing blood thinners.
• Development of a risk-benefit assessment framework for periendoscopic management.

Main Results:

• Patients on blood thinners face risks of gastrointestinal bleeding or thromboembolism during the periendoscopic period.
• Individualized assessment of thromboembolic risk (off anticoagulation) and bleeding risk (from endoscopy) is essential.
• Understanding the mechanisms and indications of different blood thinners is critical for management.

Conclusions:

• Optimal management involves a thorough risk assessment of both bleeding and thromboembolism.
• Endoscopic procedures should be timed and managed to ensure patient safety.
• Clear protocols are needed for the periendoscopic management of patients on blood thinners.